[Pinaverium bromide and functional colonic disease (double-blind study].
D000328:Adult; D000368:Aged; D000700:Analgesics / Q000009:adverse effects / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D003109:Colonic Diseases, Functional / Q000188:drug therapy*; D004311:Double-Blind Method; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009025:Morpholines / Q000009:adverse effects / Q000627:therapeutic use*; D010276:Parasympatholytics / Q000009:adverse effects / Q000627:therapeutic use*; D010919:Placebos; D000644:Quaternary Ammonium Compounds / Q000009:adverse effects / Q000627:therapeutic use
D000700:Analgesics; D009025:Morpholines; D010276:Parasympatholytics; D010919:Placebos; D000644:Quaternary Ammonium Compounds; C013199:pinaverium
Bromure de pinavérium et colopathie fonctionnelle (etude à double insu).